8 Recruiting Advanced Non-Small Cell Lung Cancer Phase 2 Clinical Trials
Active phase 2 studies for advanced non-small cell lung cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Advanced Non-Small Cell Lung Cancer studiesPhase 2 Studies for Advanced Non-Small Cell Lung Cancer
🔵 Active, Not Recruiting Phase2
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
📍 The Oncology Institute of Hope and Innovation — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
📍 Arizona Clinical Research Center — Tucson, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Study With Various Immunotherapy Treatments in Participants With Lung Cancer
📍 University of Alabama at Birmingham (UAB) — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
📍 Local Institution - 007-556-A — Goodyear, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
📍 Banner MD Anderson Cancer Center at Banner Gateway Medical Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2
Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔